Digital Therapeutics - Australia

Australia

Highlights

Revenue in the Digital Therapeutics market is projected to reach US$3.11 in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 1,801.00%, resulting in a projected market volume of US$7.72m by 2029.
User penetration will be 0.90% in 2024 and is expected to hit 2.10% by 2029.
The average revenue per user (ARPU) is expected to amount to US$0.00.
In global comparison, most revenue will be generated United States (US$3.15k in 2024).

Market definitionIn-Scope/Out-of-scopeMarket structureReportsMethodology

The Digital Therapeutics market in Australia is experiencing significant growth and development, particularly in the areas of Diabetes care, Mental & Behavioral health, Cardiovascular Health, and Musculoskeletal Health.

Customer preferences: Customers in Australia are increasingly seeking out digital solutions to support their healthcare needs, driving the demand for Digital Therapeutics products. With a tech-savvy population that values convenience and accessibility, the adoption of digital tools for managing health conditions is on the rise.

Trends in the market: In Australia, there is a growing trend towards personalized and data-driven healthcare solutions, which is fueling the demand for Digital Therapeutics products. Companies are leveraging advanced technologies such as artificial intelligence and machine learning to develop tailored interventions for specific therapeutic areas like Diabetes care, Mental & Behavioral health, Cardiovascular Health, and Musculoskeletal Health. This trend is reshaping the healthcare landscape in Australia and paving the way for more targeted and effective treatment options.

Local special circumstances: Australia's healthcare system is known for its high quality and accessibility, but it also faces challenges such as an aging population and rising chronic disease burden. Digital Therapeutics offer a promising solution to these challenges by providing remote monitoring, personalized interventions, and continuous support to patients. The government's increasing focus on digital health initiatives and telehealth services further supports the growth of the Digital Therapeutics market in Australia.

Underlying macroeconomic factors: The Australian economy is witnessing steady growth, which is boosting investments in healthcare innovation and technology. With a strong regulatory framework and supportive policies in place, the Digital Therapeutics market in Australia is poised for further expansion. Additionally, the increasing awareness among healthcare professionals and patients about the benefits of Digital Therapeutics is driving acceptance and adoption across the country.

Data coverage:

The data encompasses B2C enterprises. Figures are based on revenues and user data of relevant mobile applications and consumer electronics companies.

Modeling approach / Market size:

Market sizes are determined through a combined top-down and bottom-up approach, building on a specific rationale for each market segment. As a basis for evaluating markets, we use annual financial reports of key players, industry reports, third-party reports, and survey results from primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as GDP, population, internet penetration, smartphone penetration, consumer spending, and healthcare spending. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, the S-curve function and exponential trend smoothing are well suited for forecasting digital products and services due to the non-linear growth of technology adoption.

Additional notes:

The market is updated twice a year in case market dynamics change. The impact of the COVID-19 pandemic and the Russia-Ukraine war is considered at a country-specific level.